#$%^&*AU2018206705A120180802.pdf#####C: Interwovn NRPortbl DCC AAR 17360589 Idocx-7 07/2018 ABSTRACT The present invention relates to novel therapies for treating autoimmune and inflammatory diseases. More specifically, the present invention relates to a use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases.